The aim of our study was to evaluate the hypothesis that a combination of tumor diameter and immunohistochemical expression of cyclin D3 and Gal-3 is helpful in distinguishing between benign and malignant thyroid lesions. This evidence concerns the gene LGALS3 and neoplasm.